Analyst consensus rating
Alpha Tau Medical Analyst Rating: Buy
DRTS is rated Buy by 5 analysts with a $14.40 target. As of 2026-08-23.
Direct answer
Alpha Tau Medical's consensus rating is Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $14.40.
Forecast evidence checked August 23, 2026.
Get free Alpha Tau Medical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $14.92
- Average price target
- $14.40
- High price target
- $17.00
- Low price target
- $8.00
- Low target gap
- -46.4%
- Target upside
- -3.5%
- High target gap
- +13.9%
- Target range width
- 60.3%
- Consensus rating
- Buy
- Analysts
- 5
- Evidence date
- August 23, 2026
- Valid through
- August 30, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Alpha Tau Medical?
Alpha Tau Medical has a verified Buy consensus. The same dataset has an average price target of $14.40.
How far are Alpha Tau Medical's low and high targets from the recorded price?
The low target implies -46.4%, while the high target implies +13.9%.
How many analysts are included in Alpha Tau Medical's consensus?
The verified consensus includes 5 analysts.
How is Alpha Tau Medical's target upside or downside calculated?
The average target of $14.40 is divided by the recorded price of $14.92, then one is subtracted to produce -3.5%. This does not guarantee a future return.
When was Alpha Tau Medical's analyst forecast verified?
The data was verified on 2026-08-23. The dataset is valid through 2026-08-30.